Protein hnRNP A1 and its derivative Up1 unfold quadruplex DNA in the human KRAS promoter: implications for transcription

被引:127
作者
Paramasivam, Manikandan [1 ]
Membrino, Alexandro [1 ]
Cogoi, Susanna [1 ]
Fukuda, Hirokazu [2 ]
Nakagama, Hitoshi [2 ]
Xodo, Luigi E. [1 ]
机构
[1] Sch Med, Dept Biomed Sci & Technol, I-33100 Udine, Italy
[2] Natl Canc Ctr, Div Biochem, Res Inst, Chuo Ku, Tokyo 1040045, Japan
关键词
TELOMERIC G-QUADRUPLEXES; GROWTH-FACTOR GENE; C-MYC PROMOTER; RAS ONCOGENES; HUMAN GENOME; TETRAPLEX STRUCTURES; PROXIMAL PROMOTER; IN-VITRO; BINDING; CANCER;
D O I
10.1093/nar/gkp138
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The promoter of the human KRAS proto-oncogene contains a structurally polymorphic nuclease hypersensitive element (NHE) whose purine strand forms a parallel G-quadruplex structure (called 32R). In a previous work we reported that quadruplex 32R is recognized by three nuclear proteins: PARP-1, Ku70 and hnRNP A1. In this study we describe the interaction of recombinant hnRNP A1 (A1) and its derivative Up1 with the KRAS G-quadruplex. Mobility-shift experiments show that A1/Up1 binds specifically, and also with a high affinity, to quadruplex 32R, while CD demonstrates that the proteins strongly reduce the intensity of the 260 nm-ellipticitythe hallmark for parallel G4-DNAand unfold the G-quadruplex. Fluorescence resonance energy transfer melting experiments reveal that A1/Up1 completely abrogates the cooperative quadruplex-to-ssDNA transition that characterizes the KRAS quadruplex and facilitates the association between quadruplex 32R and its complementary polypyrimidine strand. When quadruplex 32R is stabilized by TMPyP4, A1/Up1 brings about only a partial destabilization of the G4-DNA structure. The possible role played by hnRNP A1 in the mechanism of KRAS transcription is discussed.
引用
收藏
页码:2841 / 2853
页数:13
相关论文
共 49 条
[1]   MOST HUMAN CARCINOMAS OF THE EXOCRINE PANCREAS CONTAIN MUTANT C-K-RAS GENES [J].
ALMOGUERA, C ;
SHIBATA, D ;
FORRESTER, K ;
MARTIN, J ;
ARNHEIM, N ;
PERUCHO, M .
CELL, 1988, 53 (04) :549-554
[2]   RAS ONCOGENES - THEIR ROLE IN NEOPLASIA [J].
BARBACID, M .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1990, 20 (03) :225-235
[3]   Pancreatic cancer biology and genetics [J].
Bardeesy, N ;
DePinho, RA .
NATURE REVIEWS CANCER, 2002, 2 (12) :897-909
[4]  
BOS JL, 1989, CANCER RES, V49, P4682
[5]   MUTATIONS IN THE KRAS2 ONCOGENE DURING PROGRESSIVE STAGES OF HUMAN-COLON CARCINOMA [J].
BURMER, GC ;
LOEB, LA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (07) :2403-2407
[6]  
CLEGG RM, 1992, METHOD ENZYMOL, V211, P353
[7]  
COBIANCHI F, 1986, J BIOL CHEM, V261, P3536
[8]   Structural polymorphism within a regulatory element of the human KRAS promoter:: formation of G4-DNA recognized by nuclear proteins [J].
Cogoi, Susanna ;
Paramasivam, Manikandan ;
Spolaore, Barbara ;
Xodo, Luigi E. .
NUCLEIC ACIDS RESEARCH, 2008, 36 (11) :3765-3780
[9]   G-quadruplex formation within the promoter of the KRAS proto-oncogene and its effect on transcription [J].
Cogoi, Susanna ;
Xodo, Luigi E. .
NUCLEIC ACIDS RESEARCH, 2006, 34 (09) :2536-2549
[10]   Identification of a New G-Quadruplex Motif in the KRAS Promoter and Design of Pyrene-Modified G4-Decoys with Antiproliferative Activity in Pancreatic Cancer Cells [J].
Cogoi, Susanna ;
Paramasivam, Manikandan ;
Filichev, Vyacheslav ;
Geci, Imrich ;
Pedersen, Erik B. ;
Xodo, Luigi E. .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (02) :564-568